Analysis of the reasons for accepting or declining participation in genetic research for breast cancer: A hospital-based population study

Angelo Paradiso, Michele Bruno, Onofrio Cicoria, Maria Digennaro, Salvafore Longo, Michele Rinaldi, Francesco Schittulli

Research output: Contribution to journalArticle

Abstract

The majority of a hospital-based population accepted to participate in a molecular screening project for familial breast cancer, giving their informed consent to blood sampling. Only 9.5% of patients declined to sign the consent form. Here we report the reasons for refusal and we critically review our methodological approach to obtain consent for a blood test for genetic research in a clinical setting.

Original languageEnglish
Pages (from-to)435-436
Number of pages2
JournalTumori
Volume90
Issue number4
Publication statusPublished - Jul 2004

Keywords

  • Breast cancer risk
  • Genetic research
  • Hospital-based population
  • Informed consent

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Analysis of the reasons for accepting or declining participation in genetic research for breast cancer: A hospital-based population study'. Together they form a unique fingerprint.

  • Cite this

    Paradiso, A., Bruno, M., Cicoria, O., Digennaro, M., Longo, S., Rinaldi, M., & Schittulli, F. (2004). Analysis of the reasons for accepting or declining participation in genetic research for breast cancer: A hospital-based population study. Tumori, 90(4), 435-436.